These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2079345)

  • 1. [Mixed connective tissue disease and correlated diseases].
    Rebora A; Parodi A
    G Ital Dermatol Venereol; 1990 Sep; 125(9):357-62. PubMed ID: 2079345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
    Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
    Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
    Bodolay E; Szegedi G
    Orv Hetil; 2002 Feb; 143(5):229-33. PubMed ID: 11875835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Sharp syndrome ("mixed connective tissue disease")].
    Rosenthal M
    Schweiz Med Wochenschr; 1976 Jan; 106(5):129-34. PubMed ID: 1082643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
    Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
    Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of antibodies to a 68 kDa U1RNP polypeptide in connective tissue disease.
    McHugh N; James I; Maddison P
    J Rheumatol; 1990 Oct; 17(10):1320-8. PubMed ID: 1701488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of anticardiolipin antibodies in connective tissue diseases].
    Scagliusi P; Tortorelli E; L'Abbate MC; Pipitone V
    Minerva Med; 1989 Oct; 80(10):1059-68. PubMed ID: 2682375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
    Yamagata H; Akizuki M; Tojo T; Homma M
    Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mixed connective tissue disease--etiology, pathogenesis, clinical significance, treatment].
    Zdrojewicz Z; Budzyń-Kozioł E; Puławska J
    Postepy Hig Med Dosw; 1999; 53(5):751-66. PubMed ID: 10645148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sicca symptoms and anti-SSA/Ro antibodies are common in mixed connective tissue disease.
    Setty YN; Pittman CB; Mahale AS; Greidinger EL; Hoffman RW
    J Rheumatol; 2002 Mar; 29(3):487-9. PubMed ID: 11908561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
    Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
    J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
    Lundberg I; Hedfors E
    J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.
    Alarcón-Segovia D; Cardiel MH
    J Rheumatol; 1989 Mar; 16(3):328-34. PubMed ID: 2724251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
    Margaux J; Hayem G; Palazzo E; Chazerain P; De Bandt M; Haim T; Kahn MF; Meyer O
    Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and serologic course of patients with mixed connective tissue disease].
    López-Longo FJ; Fernández J; Monteagudo I; Rodríguez-Mahou M; Sánchez-Atrio AI; Pérez T; Escalona M; González CM; Lapointe N; Carreño L
    Rev Clin Esp; 1994 Sep; 194(9):682-8. PubMed ID: 7984796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary arterial hypertension related to connective tissue diseases].
    Pehlivan O; Inanç M
    Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():57-62. PubMed ID: 20819768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of DLco for the early diagnosis of pulmonary involvement in collagen diseases].
    Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Apr; 31(4):480-5. PubMed ID: 8515621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's phenomenon in mixed connective tissue disease.
    Grader-Beck T; Wigley FM
    Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.